Peilong Lai

2.2k total citations · 1 hit paper
52 papers, 1.4k citations indexed

About

Peilong Lai is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Peilong Lai has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 19 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Peilong Lai's work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Immune Cell Function and Interaction (10 papers). Peilong Lai is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Immune Cell Function and Interaction (10 papers). Peilong Lai collaborates with scholars based in China, United Kingdom and United States. Peilong Lai's co-authors include Jianyu Weng, Xin Du, Chang He, Tian Zhou, Duanqing Pei, Zenan Yuan, Liyan Guo, Suxia Geng, Xiaomei Chen and Suijing Wu and has published in prestigious journals such as Blood, Cell Metabolism and Oncogene.

In The Last Decade

Peilong Lai

48 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges and advances in clinical applications of mesenchymal stromal cells

2021 476 citations Tian Zhou, Jianyu Weng et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peilong Lai China	15	716	452	286	265	258	52	1.4k
Xin Du China	20	849 1.2×	539 1.2×	512 1.8×	449 1.7×	314 1.2×	74	1.8k
Amit Nathwani United Kingdom	24	601 0.8×	429 0.9×	302 1.1×	311 1.2×	142 0.6×	67	1.5k
Weiqi Lei United States	10	805 1.1×	220 0.5×	429 1.5×	197 0.7×	154 0.6×	11	1.6k
Shyam A. Patel United States	16	428 0.6×	477 1.1×	406 1.4×	233 0.9×	193 0.7×	61	1.1k
Satoru Otsuru United States	26	750 1.0×	624 1.4×	242 0.8×	211 0.8×	205 0.8×	65	2.1k
Jan A. Burger United States	10	478 0.7×	956 2.1×	278 1.0×	409 1.5×	177 0.7×	26	1.6k
Daniele Reverberi Italy	18	869 1.2×	664 1.5×	198 0.7×	314 1.2×	423 1.6×	46	1.6k
Olli Tynninen Finland	24	710 1.0×	496 1.1×	460 1.6×	340 1.3×	327 1.3×	64	2.0k
Krzysztof M. Mrozik Australia	22	753 1.1×	735 1.6×	231 0.8×	123 0.5×	163 0.6×	34	1.7k
Marta Serafini Italy	23	675 0.9×	509 1.1×	476 1.7×	315 1.2×	121 0.5×	67	1.8k

Countries citing papers authored by Peilong Lai

Since Specialization

Citations

This map shows the geographic impact of Peilong Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peilong Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peilong Lai more than expected).

Fields of papers citing papers by Peilong Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peilong Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peilong Lai. The network helps show where Peilong Lai may publish in the future.

Co-authorship network of co-authors of Peilong Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Peilong Lai. A scholar is included among the top collaborators of Peilong Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peilong Lai. Peilong Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Yun‐Yun, Xueqing Zhang, Lili Chen, et al.. (2025). Injectable tert-butylphenylacetic acid/acrylated β-cyclodextrin-based hydrogels for co-delivery of CAR-T cells and IL-15 in solid tumor therapy. Materials Today Bio. 35. 102421–102421.

Yang, Lin, Weiya Zhang, Jianyu Weng, et al.. (2024). Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies. Journal of Hematology & Oncology. 17(1). 105–105. 38 indexed citations

Wu, Miao, Yawen Wang, Yulian Wang, et al.. (2023). Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular Medicine. 29(1). 59–59. 14 indexed citations

Chen, Xiaomei, Yulian Wang, Xin Huang, et al.. (2023). Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice. International Immunopharmacology. 117. 109746–109746. 3 indexed citations

Deng, Chengxin, Ping Wu, Xin Huang, et al.. (2023). Outcomes of intermediate or high‐risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience. Clinical and Translational Science. 17(1). e13711–e13711. 1 indexed citations

Chen, Xiaomei, Bowen Liu, Chao Li, et al.. (2023). Stem cell-based therapy for COVID-19. International Immunopharmacology. 124(Pt A). 110890–110890. 3 indexed citations

Lai, Peilong, et al.. (2022). miR-103-3p regulates the differentiation of bone marrow mesenchymal stem cells in myelodysplastic syndrome. Biocell. 47(1). 133–141. 1 indexed citations

Zhou, Lijuan, Yulian Wang, Chao Li, et al.. (2022). Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia. Frontiers in Oncology. 12. 1057153–1057153. 1 indexed citations

Wang, Jinghua, Weida Wang, Hao Chen, et al.. (2021). C‐Type Lectin‐Like Molecule‐1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study. BioMed Research International. 2021(1). 6643948–6643948. 12 indexed citations

10.

Luo, Chengwei, Peilong Lai, Lin Wei, et al.. (2020). von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy. Clinical and Applied Thrombosis/Hemostasis. 26. 2873291212–2873291212. 10 indexed citations

11.

Lai, Peilong, Jianyu Weng, Liyan Guo, Xiaomei Chen, & Xin Du. (2019). Novel insights into MSC-EVs therapy for immune diseases. Biomarker Research. 7(1). 6–6. 111 indexed citations

12.

Geng, Suxia, et al.. (2019). Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine. Oncology Letters. 18(5). 4457–4466. 5 indexed citations

13.

Lai, Peilong, Xiaomei Chen, Liyan Guo, et al.. (2018). A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD. Journal of Hematology & Oncology. 11(1). 135–135. 137 indexed citations

14.

Qin, Le, Yunxin Lai, Ruocong Zhao, et al.. (2017). Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells. Journal of Hematology & Oncology. 10(1). 68–68. 79 indexed citations

15.

Wang, Yulian, Peilong Lai, Xiaomei Chen, et al.. (2017). Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg. Scientific Reports. 7(1). 3603–3603. 9 indexed citations

16.

Geng, Suxia, Jianyu Weng, Shaohua Chen, et al.. (2015). Abnormalities in the T Cell Receptor Vδ Repertoire and Foxp3 Expression in Refractory Anemia with Ringed Sideroblasts. DNA and Cell Biology. 34(9). 588–595. 2 indexed citations

17.

Chen, Xiaomei, Jianyu Weng, Yulian Wang, et al.. (2015). Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia. Blood. 126(23). 4897–4897. 2 indexed citations

18.

Geng, Suxia, Jianyu Weng, Xin Du, et al.. (2012). Comparison of the Distribution and Clonal Expansion Features of the T-Cell γδ Repertoire in Myelodysplastic Syndrome-RAEB and RAEB with Progression to AML. DNA and Cell Biology. 31(10). 1563–1570. 11 indexed citations

19.

Weng, Jianyu, Peilong Lai, Ling Wei, et al.. (2012). Bortezomib Modulates Regulatory T Cell Subpopulations in the Process of Acute Graft-Versus-Host Disease. Clinical Laboratory. 59(01+02/2013). 51–8. 7 indexed citations

20.

Lai, Peilong, Jianyu Weng, Rong Guo, et al.. (2011). Gene Expression Profiling-Based Identification of CD28 and PI3K as New Biomarkers for Chronic Graft-Versus-Host Disease. DNA and Cell Biology. 30(12). 1019–1025. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact